Bank Of America Corp Uro Gen Pharma Ltd. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Bank Of America Corp holds 66,086 shares of URGN stock, worth $818,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,086
Previous 53,063
24.54%
Holding current value
$818,144
Previous $795,000
39.37%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding URGN
# of Institutions
120Shares Held
39.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.56MShares$44 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$40.9 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$38.2 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.91MShares$36 Million12.93% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$30.3 Million0.11% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $282M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...